Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  A ALIMENTARY TRACT AND METABOLISM
    A04 ANTIEMETICS AND ANTINAUSEANTS
      A04A ANTIEMETICS AND ANTINAUSEANTS
        A04AD Other antiemetics
          A04AD14 Rolapitant [DG:DG01868]
            D08988  Rolapitant hydrochloride (USAN) <US>

USP drug classification [BR:br08302]
  Antiemetics
    Emetogenic Therapy Adjuncts
      Rolapitant [DG:DG01868]
        D08988  Rolapitant hydrochloride (USAN)

Drug groups [BR:br08330]
  Gastrointestinal agent
    DG01762  Antiemetic
      DG01868  Rolapitant
        D08988  Rolapitant hydrochloride
  Metabolizing enzyme substrate
    DG01633  CYP3A/CYP3A4 substrate
      DG02913  CYP3A4 substrate
        DG01868  Rolapitant
          D08988  Rolapitant hydrochloride
  Metabolizing enzyme inhibitor
    DG01645  CYP2D6 inhibitor
      DG01868  Rolapitant
        D08988  Rolapitant hydrochloride

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Tachykinin
        TACR1 (NK1R) [HSA:6869] [KO:K04222]
          D08988  Rolapitant hydrochloride (USAN) <US>

New drug approvals in the USA [br08319.html]
  D08988

New drug approvals in the USA, Europe and Japan [br08328.html]
  D08988

Drug metabolizing enzymes and transporters [br08309.html]
  D08988